Compare AQST & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AQST | TALK |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 872.7M |
| IPO Year | 2007 | 2020 |
| Metric | AQST | TALK |
|---|---|---|
| Price | $4.50 | $5.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $9.00 | $6.42 |
| AVG Volume (30 Days) | ★ 3.5M | 1.7M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 300.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | $27,600,000.00 |
| Revenue This Year | $10.08 | $26.02 |
| Revenue Next Year | $49.60 | $21.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 0.77 | ★ 9.09 |
| 52 Week Low | $2.94 | $2.49 |
| 52 Week High | $7.55 | $5.25 |
| Indicator | AQST | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 60.99 | 58.26 |
| Support Level | $4.03 | $5.19 |
| Resistance Level | $4.69 | N/A |
| Average True Range (ATR) | 0.24 | 0.02 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 73.97 | 100.00 |
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Talkspace Inc is a virtual behavioral healthcare company offering its members convenient and affordable access to a fully-credentialed network of qualified providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. It is a single destination for comprehensive mental health care, including therapy for individuals, couples, and teens, as well as psychiatric treatment and medication management (18+), and self-guided tools and resources. The company's customers include Health insurance plans from commercial and government institutions, and employee assistance programs, Direct-to-Enterprise, and Individual subscribers. The company operates as a single segment.